Nanhua Bio-Medicine Co.,Ltd. Posted 3.2 Million Yuan Net Loss in First Quarter of 2022

Nanhua Bio-Medicine Co.,Ltd. (南华生物医药股份有限公司) (000504.SZ) reported a net loss of 3.2 million yuan in the first quarter of 2022, reversing a net profit of 1.7 million yuan for the same period in the previous year.

Meanwhile, the company posted 64.8 million yuan in revenue, up 95.6% year-on-year.

At the end of the reporting period, it had 651.6 million yuan in total assets and 544.5 million yuan in total liabilities, with a liability-to-asset ratio of 83.6%.